Pilot and Feasibility Program
Pilot and Feasibility Program
批准号:
10666471
负责人:
Roland W Stein
金额:
$42.37万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
未结题
起止时间:
1996-12-01 至 2027-03-31
关键词:
AbbreviationsAcademic Medical CentersAmericanAwardAwarenessBehavioral ResearchBiochemistryBiomedical ResearchBiophysicsCardiovascular systemCategoriesClinical DataClinical ResearchClinical and Translational Science AwardsCommunitiesCore FacilityCritiquesDNADataDiabetes MellitusDigestive System DisordersDirect CostsDisciplineEffectivenessEndocrinologyEngineeringExtramural ActivitiesFacultyFundingFunding MechanismsGoalsGrantHealth Services ResearchIndividualInfrastructureInstitutionInsulin-Dependent Diabetes MellitusLaboratoriesLeadershipLinkLungMeasuresMedicineMolecularNon-Insulin-Dependent Diabetes MellitusObesityOphthalmologyPeer Review GrantsPhysiologyPilot ProjectsProgram ReviewsPublicationsReportingResearchResearch PersonnelResearch Project GrantsResearch ProposalsResearch SupportReview CommitteeRheumatologyStudy SectionTimeTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkbiobankcareercareer developmentclinical centerclinical investigationepidemiology studyinnovationmembernovelprogramssuccess
中文摘要
试点和可行性方案(P&F):项目摘要/摘要
自1978年成立以来,P&F计划已资助了132个项目(包括2020个项目)。这个项目有
通过为支持糖尿病相关项目提供资金,这是非常有价值和有效的。这个
该计划的目标是支持新研究人员(他们几乎没有或没有)进行的小型研究项目
独立研究支持)或第一次转向糖尿病研究的老牌研究人员
时间到了。大多数提案属于前一类(即2016-2020年期间授予的15项赠款中的13项)。
通常每年都会启动三个新项目。在全校范围内征求建议书后,有三个
个人(两名内部人员和一名外部人员)审查每笔赠款。对这项提议的批评是
由P&F审查委员会评估(相当于NIH的研究部分),并分配每个提案
优先考虑的分数。然后将提案和优先级分数提交给DRTC执行委员会
(相当于美国国立卫生研究院理事会),以作出资金决定。对第二年研究的支持在以下情况下授予
令人满意的工作在第一年内完成,如果在此期间没有获得对项目的支助。
这一项目的成功率,衡量的是仍参与其中的调查人员的数量
糖尿病研究,出版物,和/或谁将他们的P&F转化为国家奖励的,同行评审的赠款,
非常高。此外,该计划还为来自不同部门/部门的申请提供资金
这个机构。例如,来自分子生理学和生物物理学、风湿病学、
心血管医学、肺科学、内分泌学、眼科学、工程学和生物化学
在过去的四年里都得到了资助。P&F计划还提供VDRC在
范德比尔特科学界,从而使科学界更了解其研究努力和
核心设施。VDRC P&F计划的重要性和有效性通过以下决定得到强调
范德比尔特领导层将在下一个资金周期继续为该项目提供额外的P&F资金。
英文摘要
Pilot & Feasibility Program (P&F): Project Summary/Abstract
The P&F program has funded 132 projects (including 2020) since its inception in 1978. This program has
been extremely valuable and effective by providing funding for the support of diabetes-related projects. The
goal of the program is to support small research projects by new investigators (who have little or no
independent research support) or established investigators who are turning to diabetes research for the first
time. Most of the proposals are in the former category (i.e., 13 of 15 grant awarded between 2016-2020).
Three new projects are normally initiated each year. After a university-wide solicitation of proposals, three
individuals (two internal and one external to the institution) review each grant. The critiques of the proposal are
evaluated by the P&F Review Committee (equivalent to an NIH study section), and each proposal is assigned
a priority score. The proposals and priority scores are then presented to the DRTC Executive Committee
(equivalent to the NIH Council) for a funding decision. Support for a second year of research is awarded when
satisfactory work is completed in year one and if support for the projects has not been obtained in the interim.
The success rate of this program, measured either by the number of investigators who remain involved in
diabetes research, publications, and/or who convert their P&F into a nationally awarded, peer-reviewed grant,
is very high. In addition, this program funds applications from a wide variety of Departments/Divisions within
the institution. For example, faculty members from Molecular Physiology and Biophysics, Rheumatology,
Cardiovascular Medicine, Pulmonary, Endocrinology, Ophthalmology, Engineering, and Biological Chemistry
were funded over the past four years. The P&F program also provides visibility for the VDRC within the
Vanderbilt scientific community and thus makes the scientific community more aware of its research efforts and
core facilities. The importance and effectiveness of the VDRC P&F program is underscored by the decision of
the Vanderbilt leadership to continue to provide additional P&F funds for this program in the next funding cycle.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the Role of MafA in Islet Beta Cells
-
批准号:8488438
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2011
-
负责人:Roland W Stein
-
依托单位:
Defining the Role of MafA in Islet Beta Cells
-
批准号:8690837
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2011
-
负责人:Roland W Stein
-
依托单位:
Defining the Role of MafA in Islet Beta Cells
-
批准号:8308376
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2011
-
负责人:Roland W Stein
-
依托单位:
Defining the Role of MafA in Islet Beta Cells
-
批准号:8193420
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2011
-
负责人:Roland W Stein
-
依托单位:
Analyzing the MafB transcription factor in islet beta cell formation and function
-
批准号:7651177
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2009
-
负责人:Roland W Stein
-
依托单位:
Analyzing the MafB transcription factor in islet beta cell formation and function
-
批准号:7896515
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2009
-
负责人:Roland W Stein
-
依托单位:
PILOT AND FEASIBILITY PROGRAM
-
批准号:7284655
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2007
-
负责人:Roland W Stein
-
依托单位:
MafA in B cell development and function
-
批准号:7056488
-
项目类别:
-
资助金额:$34.85万
-
财政年份:2005
-
负责人:Roland W Stein
-
依托单位:
IDENTIFICATION/CHARACTERIZATION OF RIPE3B1
-
批准号:6466606
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2001
-
负责人:Roland W Stein
-
依托单位:
FACTORS IMPORTANT IN BETA2 TARGETED ACTIVATION
-
批准号:2758408
-
项目类别:
-
资助金额:$24.3万
-
财政年份:1998
-
负责人:Roland W Stein
-
依托单位:
FACTORS IMPORTANT IN BETA2 TARGETED ACTIVATION
-
批准号:2906355
-
项目类别:
-
资助金额:$25.94万
-
财政年份:1998
-
负责人:Roland W Stein
-
依托单位:
FACTORS IMPORTANT IN BETA2 TARGETED ACTIVATION
-
批准号:6381458
-
项目类别:
-
资助金额:$27.33万
-
财政年份:1998
-
负责人:Roland W Stein
-
依托单位:
FACTORS IMPORTANT IN BETA2 TARGETED ACTIVATION
-
批准号:6178077
-
项目类别:
-
资助金额:$26.53万
-
财政年份:1998
-
负责人:Roland W Stein
-
依托单位:
Control of islet beta specific pdx-1 and mafA transcription
-
批准号:7460656
-
项目类别:
-
资助金额:$35.92万
-
财政年份:1995
-
负责人:Roland W Stein
-
依托单位:
Control of islet beta specific pdx-1 and mafA transcription
-
批准号:7264593
-
项目类别:
-
资助金额:$38.55万
-
财政年份:1995
-
负责人:Roland W Stein
-
依托单位:
PDX-1,A TRANSCRIPTIONAL ACTIVATOR OF THE INSULIN GENE
-
批准号:6096276
-
项目类别:
-
资助金额:$34.11万
-
财政年份:1995
-
负责人:Roland W Stein
-
依托单位:
Control of islet b-specific pdx-1 & mafA transcription
-
批准号:7040273
-
项目类别:
-
资助金额:$7.59万
-
财政年份:1995
-
负责人:Roland W Stein
-
依托单位:
Control of Islet Beta Specific PDX-1 and MafA Transcription
-
批准号:8387588
-
项目类别:
-
资助金额:$42.12万
-
财政年份:1995
-
负责人:Roland W Stein
-
依托单位:
PDX-1,A TRANSCRIPTIONAL ACTIVATOR OF THE INSULIN GENE
-
批准号:6635048
-
项目类别:
-
资助金额:$33.98万
-
财政年份:1995
-
负责人:Roland W Stein
-
依托单位:
KEY TRANSCRIPTIONAL FACTOR OF INSULIN GENE PDX-1
-
批准号:2151239
-
项目类别:
-
资助金额:$22.98万
-
财政年份:1995
-
负责人:Roland W Stein
-
依托单位:
海外基金